News | April 11, 2007

More than Half of All Programs Provide Financial Incentives for Better Quality Care, Survey Says

April 12, 2007 - In the first published nationwide survey of state Medicaid programs on "pay-for-performance" practices, more than half of all programs state that they provide financial incentives to health care providers for better quality care. Almost 85 percent of states plan to have pay-for-performance programs within five years. Researchers also found that most current programs focus on women's, children's and adolescents' health issues. The study is published today by The Commonwealth Fund, a private foundation working toward a high-performance health system. Authors are from IPRO, a not-for-profit quality evaluation and improvement organization and The Kuhmerker Consulting Group, LLC, a health care consulting firm.

"Medicaid is a major source of funding of health care in every state and, therefore, has a significant influence on the health care system," said Thomas Hartman, Vice President for Health Care Quality Improvement for IPRO and co- author of the study. "But each state operates its program independently of the others. We thought it would be helpful to provide a detailed snapshot of what is taking place around the nation so that state officials have solid information on which to base decisions about pay-for-performance."

Hartman and co-author Kathryn Kuhmerker, President of the Kuhmerker Group and former Medicaid Director for New York State, found several trends. Nine Medicaid programs (Arizona, Kansas, Maine, Minnesota, New Hampshire, New York, Oregon, Vermont, and Washington) are joining in statewide and regional pay- for-performance and quality improvement efforts, and others are considering entering into such collaborations. Health information technology is a focus of numerous Medicaid pay-for-performance programs (Alabama, Alaska, Arizona, Massachusetts,
Minnesota, New York, Pennsylvania, and Utah). In these programs, providers are given incentives to adopt electronic health records and electronic prescribing, often in conjunction with the collaborative efforts described above. Access to care is a continuing concern of state Medicaid directors, and that concern is reflected in the approaches they take in this area. An overwhelming majority of Medicaid directors state that their pay-for-performance priority is on improving quality, not on reducing cost.

"Medicaid is not a new entrant into the field of pay-for-performance," according to Kuhmerker. "We learned that almost half of all programs, in fact, are more than five years old." More than 70 percent of planned new programs are expected to start in the next two years.

"The effort to link health care spending and quality is a growing phenomenon in the health care industry," said Karen Davis, President, The Commonwealth Fund. "Both quality and efficiency are key components of a high performance health system, and it is encouraging to see the states rewarding provider efforts in these areas."

The study found that 70 percent of existing Medicaid pay-for-performance programs operate in managed care or primary care case management (PCCM) environments, with a focus on preventive health services and children's, adolescents' and women's health issues.

"New programs are still focused mainly on managed care and PCCM providers," Kuhmerker said, "but appear to be shifting their emphasis to the quality and cost issues related to chronic diseases like asthma and diabetes."

Hartman and Kuhmerker gathered information through a written survey sent to all state Medicaid directors, conducted follow-up interviews with the directors and their staffs, and reviewed a range of documents and Web-based resources on the programs. The study focused on programs that provide financial rewards for quality, efficiency and other program attributes. The study was conducted from May through October 2006.

"Very few states have conducted formal evaluations of their pay-for- performance programs, but most Medicaid officials believe that the overall quality of care being provided is improving as a result of these programs," said Hartman. "More research clearly needs to be done to assess the effects of pay-for-performance on the quality of care provided to Medicaid recipients."

To view a copy of the study, please go to http://www.cmwf.org or http://www.ipro.org.

Related Content

Videos | Artificial Intelligence | December 13, 2018
ITN Editor Dave Fornell and ITN Contributing Editor Greg Freiherr share their insights on the vendors showing AI prod
FDA Clears iCAD's ProFound AI for Digital Breast Tomosynthesis
Technology | Mammography | December 07, 2018
iCAD Inc. announced clearance by the U.S. Food and Drug Administration (FDA) for their latest, deep-learning, cancer...
ScreenPoint Medical and Volpara Partner to Bring AI to Breast Imaging Clinics
News | Computer-Aided Detection Software | December 04, 2018
ScreenPoint Medical has signed a memorandum of understanding (MOU) with Volpara Health Technologies. Volpara will...
Infervision Introduces AI Capabilities for Chest CT Reading
Technology | Computer-Aided Detection Software | November 30, 2018
Big data and artificial intelligence (AI) company Infervision announced the launch of InferRead CT Chest, a new product...
NeuroLogica and MaxQ AI Announce Distribution Agreement
News | Stroke | November 30, 2018
Clinical diagnostics intelligence platform company MaxQ AI and Samsung NeuroLogica announced a distribution agreement...
ScreenPoint Medical Receives FDA Clearance for Transpara Mammography AI Solution
Technology | Computer-Aided Detection Software | November 28, 2018
November 28, 2018 — ScreenPoint Medical announced it has received 510(k) clearance from the U.S.
Arterys Demonstrates AI Cloud-Based Medical Image Analysis Solutions at RSNA 2018
News | Computer-Aided Detection Software | November 26, 2018
Medical imaging software company Arterys will demonstrate its wide-ranging suite of artificial intelligence (AI)-...
QView Medical Showcases QVCAD for ABUS Exams at RSNA 2018
News | Ultrasound Women's Health | November 19, 2018
QView Medical will showcase QVCAD, the first U.S. Food and Drug Administration (FDA)-approved artificial intelligence (...
Lunit Unveiling AI-Based Mammography Solution at RSNA 2018
News | Mammography | November 15, 2018
Medical artificial intelligence (AI) software company Lunit will be returning to the 104th Radiological Society of...
MaxQ AI Receives FDA Clearance for Accipio Ix Intracranial Hemorrhage Platform
Technology | Artificial Intelligence | November 07, 2018
MaxQ AI announced that its Accipio Ix intracranial hemorrhage (ICH) detection software has received 510(k) clearance...